US Stock MarketDetailed Quotes
CLNN Clene
- 5.3000
- +0.3500+7.07%
Close Oct 4 16:00 ET
- 5.3500
- +0.0500+0.94%
Post 20:02 ET
34.29MMarket Cap-1726P/E (TTM)
5.3000High4.7701Low126.10KVolume5.0000Open4.9500Pre Close643.40KTurnover3.62%Turnover RatioLossP/E (Static)6.47MShares12.000052wk High-67.95P/B18.44MFloat Cap3.818152wk Low--Dividend TTM3.48MShs Float356.4000Historical High--Div YieldTTM10.71%Amplitude3.8180Historical Low5.1020Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Clene Stock Forum
Wed, Oct 2, 2024 at 7:21 AM EDT
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community.
LOS ANGELES, CA - (NewMediaWire) - October 2, 2024 - Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal functio...
Clene Announces New CNM-Au8® Biomarker and Clinical Efficacy Data Submitted to FDA In Support of Treatment For ALS
Clene Inc. (Nasdaq: CLNN) has submitted new CNM-Au8 biomarker and clinical efficacy data to the FDA for ALS treatment. Key findings include:
1. CNM-Au8 NfL Responders showed significant improvements in survival, functional status, and combined function and survival.
2. Long-term CNM-Au8 treatmentdemonstrated substantial survival benefits compared to matched cont...
👀👀
plz do something about how ur system calculate RS value...
No comment yet